Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Phathom Pharmaceuticals Inc
(NQ:
PHAT
)
17.82
-0.00 (-0.03%)
Streaming Delayed Price
Updated: 10:29 AM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Phathom Pharmaceuticals Inc
< Previous
1
2
3
4
Next >
Mid-Morning Market Update: Markets Mostly Lower; Albertsons Tops Q2 Estimates
October 18, 2021
Following the market opening Monday, the Dow traded down 0.32% to 35,182.99 while the NASDAQ rose 0.12% to 14,915.84. The S&P also fell, dropping 0.06% to 4,468.81. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Phathom's Vonoprazan Non-Inferior To Proton Pump Inhibitor For Esophagitis Inflammation
October 18, 2021
Phathom Pharmaceuticals Inc (NASDAQ: PHAT) has announced data from the PHALCON-EE Phase 3 trial evaluating vonoprazan versus lansoprazole for erosive esophagitis (...
Via
Benzinga
Phathom Pharma's Vonoprazan Inhibits Gastric Acid In Healthy Volunteers
September 27, 2021
Phathom Pharmaceuticals Inc (NASDAQ: PHAT) has reported results from the VONO-103 Phase 1 trial of vonoprazan in healthy subjects. The trial evaluated the effects of...
Via
Benzinga
Director Of Phathom Pharmaceuticals Makes $587 Thousand Sale
September 24, 2021
David A Socks, Director at Phathom Pharmaceuticals (NASDAQ:PHAT), made a large insider sell on September 22, according to a new SEC filing. What Happened: A Form 4 filing from the...
Via
Benzinga
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
August 17, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 12, 2021
May 12, 2021
Upgrades Craig-Hallum upgraded the previous rating for ShotSpotter Inc (NASDAQ:SSTI) from Hold to Buy. For the first quarter, ShotSpotter had an EPS of $0.02, compared to...
Via
Benzinga
The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs
April 30, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) AtriCure, Inc. (NASDAQ:...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.